Role of electronic registers in medicine

2026

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.59598/me-2305-6053-2026-119-2-28-44
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Electronic registries help improve the overall understanding of supervised patients and assess the feasibility and effectiveness of diagnostic, preventive, and therapeutic interventions for certain types of diseases. Analytical data from patient registries can be used to supplement international clinical guidelines, standards, and screening programs. Controlled trial registries and clinical trial registries help generate reports on increased risk of certain diseases, identify unreported associations, confirm or refute previously reported associations with severe pathologies, and expand the existing spectrum and phenotype of the disease. Disease registries, national clinical registries, portals, databases, registers of medical services and other information systems have already demonstrated many advantages, such as new ideas, additional basic knowledge, increased awareness, unique opportunities for researching population data, morbidity, treatment approaches and act as proven statistical tools. The main purpose and benefit of registries in medicine is to guide future efforts that will close knowledge gaps, improve disease management and prevention models.